Novo Nordisk said that the guide is available as an application on iTunes and is specific to company’s modern insulin analog portfolio.

NovoDose allows physicians to select the type of insulin they want to research, review suggested guidelines for dosing, titration and even blood glucose goals and provides easy touch-screen answers who use hand-held devices like PDAs or SmartPhones, when treating the patients.

Novo Nordisk Diabetes Marketing vice president Camille Lee said that the physicians are embracing the Internet as part of how they practice medicine from accessing clinical trials online to networking with peers across the country through sites like SERMO, most physicians agree that access to information online is an asset to their practice.

“We’re taking that one step further with NovoDose by literally putting that information in the palm of their hands,” Lee said.